(Q33617751)

28 July 2017

title

Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk (English)

1 reference

28 July 2017

1 reference

Hedi Schelleman

1 reference

28 July 2017

Warren B Bilker

1 reference

28 July 2017

Colleen M Brensinger

1 reference

28 July 2017

Fei Wan

1 reference

28 July 2017

Yu-Xiao Yang

1 reference

28 July 2017

Sean Hennessy

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

American Journal of Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

123

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

151-157

1 reference

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS).

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Systematic overview of warfarin and its drug and food interactions

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Genetic polymorphisms in assessing interindividual variability in delivered dose

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

The exposure odds ratio in nested case-control studies with competing risks.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

The impact of confounder selection criteria on effect estimation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2813204

Gemfibrozil interaction with warfarin sodium (coumadin)

30 October 2018

1 reference

12 December 2020

Potential interaction between warfarin and fluvastatin

1 reference

12 December 2020

Potential warfarin-fluvastatin interaction

1 reference

12 December 2020

Atorvastatin Does Not Alter the Anticoagulant Activity of Warfarin

1 reference

12 December 2020

Gemfibrozil-warfarin drug interaction resulting in profound hypoprothrombinemia

1 reference

12 December 2020

10.1016/J.AMJMED.2009.07.020

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference